The selected drugs account for approximately $41 billion in total spending under Medicare Part D between November 2023 and October 2024, or about 14% of Medicare Part D's prescription drug costs, ...

Prescription medication costs are forcing some hard choices for many Nevadans. Two years ago, a proposal that offered hope sailed through the Democrat-majority Nevada Legislature only to be vetoed ...

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

People using weight-loss injections are being warned of potential side effects that could impact their ability to drive ...

Currently, only the oral version of semaglutide, marketed as Rybelsus is available in India ... to some patients but also places the full cost burden on them,” he said. He further noted that ...

Currently, only the oral version of semaglutide, marketed as Rybelsus is available in India ... which could make the drug ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy ... life-saving treatments at lower costs." According to HHS's announcement, these drugs ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

According to HomeAdvisor, a network and marketplace made up of construction professionals, the national average range to build a home in the United States is currently between $138,937 and $531,294.